Future Market Insights (FMI) projects the global needle-free injection systems market to experience unprecedented growth, with valuations soaring to an impressive USD 667 million by 2034. This marks a substantial increase from its 2024 valuation of USD 158 million, reflecting a notable compound annual growth rate (CAGR) of 15.5% over the next decade.
The surge in the needle-free injection systems market is primarily driven by the rising demand for painless and efficient drug delivery methods. Healthcare professionals and patients alike are increasingly turning to innovative medical technologies that offer a more comfortable and effective alternative to conventional needle-based injections.
Acquire Your Sample Report Packed With The Freshest Market Data
Needle-free injection systems offer a host of advantages, including reduced risk of needlestick injuries, improved patient compliance, and enhanced precision in drug delivery. These attributes position them as a compelling choice for pharmaceutical companies, healthcare providers, and patients alike.
As the market continues to evolve, key players are expected to intensify their focus on research and development initiatives aimed at refining existing technologies and introducing innovative solutions. Additionally, strategic collaborations and partnerships are likely to play a crucial role in accelerating market penetration and driving product innovation.
With the needle-free injection systems market poised for unprecedented growth, stakeholders across the healthcare spectrum are urged to stay abreast of emerging trends and capitalize on the vast opportunities presented by this dynamic segment.
“The adoption of needle-free drug delivery devices is on the rise, driven by the need for painless and convenient medication administration. These innovative prospects offer patients a more comfortable and less invasive option for receiving medication while reducing the risk of infections and needlestick injuries. The future of drug delivery is looking brighter with the advancements in technology and the growing demand for patient-centric solutions.” opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI).
Key Takeaways from the Needle-Free Injection System Market:
- The United States needle-free injection system industry is projected to experience a CAGR of 1% through 2034.
- Japan’s needle-free injection system market is expected to demonstrate a rapid CAGR of 1% through 2034.
- The United Kingdom’s needle-free injection system industry is anticipated to see a CAGR of 5% through 2034.
- South Korea’s needle-free injection system industry showcases a significant CAGR of 8% through 2034.
- China’s needle-free injection system market is expected to display a favorable CAGR of 3% through 2034.
Competitive Landscape of the Needle-Free Injection System Market:
Research organizations such as Medical International Technology are expected to promote innovation by consistently enhancing delivery methods, usability, and safety features. The establishment of policies and regulations to guarantee the security, effectiveness, and caliber of needle-free injection devices is going to be mostly the responsibility of regulatory bodies.
The integration of needle-free systems into medical procedures by healthcare practitioners is expected to increase their utilization and stimulate market demand. Pharma Jet and Antares Pharma, pharmaceutical firms, are working with device makers to develop and market needle-free administration systems for various drugs. Technology companies that integrate AI, such as Bioject Medical Technologies, are anticipated to drive industry breakthroughs through connection and integration.
Elevate Your Strategy the Full Report Instantly
Recent Developments in the Needle-Free Injection System Market:
- Pulse NeedleFree Systems introduced the world’s first disposable line of needle-free livestock vaccination devices in August 2023, offering health and food safety benefits to pork producers at a cost comparable to conventional syringes and needles.
- The precision delivery system provider PharmaJet obtained encouraging results in September 2023 from Scancell’s Phase 2 clinical trial about using the PharmaJet Stratis System, a patient-preferred needle-free injection technique, to treat patients with incurable metastatic melanoma.
Key Companies in the Needle-Free Injection System Market:
- Pharma Jet (United States)
- Antares Pharma. (United States)
- Medical International Technology, Inc. (MIT United States)
- Bioject Medical Technologies (United States)
- Portal Instruments (United States)
- Zogenix (United States)
- Crossject (France)
- Inovio Pharmaceuticals, Inc. (United States)
- National Medical Products (China)
- Endo International plc (Ireland)
Key Segments:
By Product:
- Prefilled needle-free injectors
- Fillable needle-free injectors
By Type:
- Liquid-based needle-free injectors
- Powder-based needle-free injectors
- Projectile/depot-based needle-free injectors
By Technology:
- Jet-based needle-free injectors
- Spring-based needle-free injectors
- Micro array patch injectors
- Others
By Site of Delivery:
- Intra-dermal injectors
- Intramuscular injectors
- Subcutaneous injectors
By Usability:
- Disposable needle-free injectors
- Reusable needle-free injectors
By Application:
- Vaccine Delivery
- Insulin delivery
- Pain management
- Others
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
